HCT Regenerative is the first and only company in Taiwan to focus on processing human tissue to provide regenerative biomaterials for clinical use. Through our know-how and strategic relationships, our aim is to become the leading tissue bank in Asia. Our continued mission is to develop advanced human cellular and tissue based products (HCT/Ps) to improve patients' quality of life. Our current products include amnion membrane allografts, amnion matrix allografts, and spinal allografts that are utilized in orthopedic surgeries, sports medicine, trauma, wound management, plastic surgery, dental and more. HCT Regenerative is also open to contract processing for companies looking to enter the Asian market or for those wishing to find a reliable partner in the region.